HHS · Rule · Rel 100 (Federal Register (major agencies))
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression
Other · Health / life sciences · general, public-health, fda-guidance
Source summary
The Food and Drug Administration (FDA) is classifying the prognostic test for assessment of chronic kidney disease progression into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the prognostic test for assessment of chronic kidney disease progression. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Analyst note
HHS issued a rule affecting other. Assess operational, cost, and disclosure implications for affected client segments.
Public reaction (Reddit)
Insufficient public reaction to score sentiment.